High-level aminoglycoside resistance in group A, B, G, D (Streptococcus bovis), and viridans streptococci | Zendy

T Horodniceanu | Zendy; Annie Buu-Hoï | Zendy; F Delbos | Zendy; G Bieth | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

High-level aminoglycoside resistance in group A, B, G, D (Streptococcus bovis), and viridans streptococci

Author(s) -

T Horodniceanu,

Annie Buu-Hoï,

F Delbos,

G Bieth

Publication year - 1982

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.21.1.176

Subject(s) - streptococcus bovis , microbiology and biotechnology , kanamycin , neomycin , aminoglycoside , tetracycline , streptomycin , biology , streptococcus , chloramphenicol , streptococcus pyogenes , group a , antibiotics , medicine , bacteria , genetics , staphylococcus aureus , rumen , food science , fermentation

Of 20 clinical isolates of group A, B, G, D (Streptococcus bovis), and viridans streptococci, 5 transferred their antibiotic resistance markers into streptococcal recipients at a low frequency (10(-4) to 10(-8)) in the apparent absence of extrachromosomal elements. All strains carried genetic markers for high-level resistance to streptomycin, kanamycin, neomycin, lividomycin A, and ribostamycin, as well as resistance to macrolides and related drugs, tetracycline, and chloramphenicol.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research